Price T Rowe Associates Inc Pulmonx Corp Transaction History

Price T Rowe Associates Inc

$867 Billion
Q4 2024

A detailed history of Price T Rowe Associates Inc transactions in Pulmonx Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 33,585 shares of LUNG stock, worth $223,004. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,585

Previous 43,008 21.91%

Holding current value

$223,004

Previous $357,000 35.85%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$5.93 - $7.71 $55,878 - $72,651	-9,423 Reduced 21.91%	33,585 $229,000
Q3 2024 Nov 14, 2024	BUY	$5.59 - $8.58 $1,671 - $2,565	299 Added 0.7%	43,008 $357,000
Q2 2024 Aug 14, 2024	BUY	$5.77 - $9.82 $40,326 - $68,631	6,989 Added 19.57%	42,709 $271,000
Q1 2024 May 15, 2024	BUY	$8.71 - $14.65 $14,223 - $23,923	1,633 Added 4.79%	35,720 $332,000
Q4 2023 Feb 14, 2024	BUY	$7.89 - $13.14 $4,576 - $7,621	580 Added 1.73%	34,087 $435,000
Q3 2023 Nov 14, 2023	BUY	$9.88 - $14.0 $37,040 - $52,486	3,749 Added 12.6%	33,507 $347,000
Q2 2023 Aug 14, 2023	BUY	$10.78 - $13.65 $31,941 - $40,444	2,963 Added 11.06%	29,758 $391,000
Q1 2023 May 15, 2023	BUY	$7.49 - $12.54 $5,175 - $8,665	691 Added 2.65%	26,795 $300,000
Q4 2022 Feb 14, 2023	BUY	$4.92 - $17.35 $3,483 - $12,283	708 Added 2.79%	26,104 $220,000
Q3 2022 Nov 14, 2022	BUY	$15.35 - $23.99 $31,206 - $48,771	2,033 Added 8.7%	25,396 $424,000
Q2 2022 Aug 15, 2022	BUY	$14.0 - $27.95 $33,278 - $66,437	2,377 Added 11.33%	23,363 $344,000
Q1 2022 May 16, 2022	SELL	$21.13 - $35.65 $4,162 - $7,023	-197 Reduced 0.93%	20,986 $521,000
Q4 2021 Feb 14, 2022	SELL	$29.72 - $45.1 $11.6 Million - $17.6 Million	-390,204 Reduced 94.85%	21,183 $679,000
Q3 2021 Nov 15, 2021	BUY	$35.98 - $44.48 $786,522 - $972,332	21,860 Added 5.61%	411,387 $14.8 Million
Q2 2021 Aug 16, 2021	SELL	$37.61 - $48.0 $12.4 Million - $15.8 Million	-328,396 Reduced 45.74%	389,527 $17.2 Million
Q1 2021 May 17, 2021	BUY	$44.0 - $67.54 $15.3 Million - $23.5 Million	348,008 Added 94.08%	717,923 $32.8 Million
Q4 2020 Feb 16, 2021	BUY	$39.31 - $69.02 $14.5 Million - $25.5 Million	369,915 New	369,915 $25.5 Million

Others Institutions Holding LUNG

# of Institutions

130

Shares Held

31.4M

Call Options Held

500

Put Options Held

213K

View Full List

About Pulmonx Corp

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $247M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

More about LUNG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Pulmonx Corp Transaction History